Datasheet Methotrexate Injection - Medsafe
Data Sheet – New Zealand Hosp 2.0 1 DBL® METHOTREXATE INJECTION AND TABLETS Name of medicine Methotrexate BP Presentation DBL® Methotrexate Injection is a sterile solution of Me thotrexate BP in Water for Injections BP. Sodium chloride is included for isotonicity except in the 1 g/10 mL vial.
Download Datasheet Methotrexate Injection - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
DRUG NAME: Methotrexate - BC Cancer
www.bccancer.bc.caMethotrexate can induce a spontaneous abortion in pregnant women especially if given in the first trimester. Methotrexate therapy may result in impairment of fertility, oligospermia, and menstrual dysfunction in
METHOTREXATE 25 MG/ML SOLUTION FOR …
www.mhra.gov.ukMETHOTREXATE 25 MG/ML SOLUTION FOR INJECTION (Methotrexate) PL 18727/0015 UKPAR TABLE OF CONTENTS Lay Summary Page 2 …
methotrexate gp guidelines 2008 - Royal National …
www.rnhrd.nhs.ukMethotrexate J. Special clinical circumstances: (1) Alcohol: Any patient suspected of alcohol abuse is usually unsuitable for methotrexate therapy. Rheumatologists should advise the patients receiving methotrexate to limit their
Methotrexate for Use in Pediatric Populations
www.who.int2 Methotrexate is also polyglutamated within the cell. Polyglutamation of methotrexate within the cell by the enzyme folyl polyglutamate synthetase increases the anti-proliferative effects
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPage 1 of 6 PACKAGE LEAFLET: INFORMATION FOR THE USER Methotrexate 2.5 mg Tablets Read all of this leaflet carefully before you …